Back to results
US 6,548,301 B2Granted
Retroviral gene transfer vectors
AssigneeHeinrich-Pette-Institut
InventorsWolfram Ostertag, Christopher Baum, Markus Hildinger
Life of this patent
Estimating the term…
Abstract
The invention relates to novel retroviral gene transfer vectors, preferably expression vectors, which, because of a reduced content of viral genes, are distinguished by a higher safety standard and an expression of non-viral nucleotide sequences in higher amounts.
Claims33
A retroviral vector which contains a nucleotide sequence N of the general formula
- 5′-end—(5′-UTR)-(gag)-(ex)-(vir)—3′-end
- wherein
- the presence of (gag) is optional,
- (5′-UTR) is a non-coding nucleotide sequence which in retroviruses lies directly 5′ of the start codon of the gag gene,
- (gag) is, when present, a section of the nucleotide sequence which codes for the gag gene,
- (ex) is a non-viral nucleotide sequence and
- (vir) is a retroviral nucleotide sequence,
- wherein
- the number of nucleotides in (gag) is less than 400 bp, and the vector contains no ATG or AUG upstream of the translation start of the sequence in (ex).
6 more elements
Dependencies are inferred from the claim text.